NF-κB and JAK/STAT Signaling Pathways as Crucial Regulators of Neuroinflammation and Astrocyte Modulation in Spinal Cord Injury. [PDF]
CellsAgeeva T, Rizvanov A, Mukhamedshina Y.
europepmc +1 more source
JAK-STAT Signaling in Autoimmunity and Cancer. [PDF]
Immunotargets TherParveen S +4 more
europepmc +1 more source
Negative regulators of STAT3 signaling pathway in cancers. [PDF]
Cancer Manag Res, 2019 Wu M +7 more
europepmc +1 more source
The Dual-Edged Sword: Risks and Benefits of JAK Inhibitors in Infections. [PDF]
PathogensJarneborn A, Kopparapu PK, Jin T.
europepmc +1 more source
JAK/STAT in human diseases: a common axis in immunodeficiencies and hematological disorders. [PDF]
Front ImmunolDjidjik R +6 more
europepmc +1 more source
JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid. [PDF]
Front ImmunolLin X, Li X, Zhai Z, Zhang M.
europepmc +1 more source
Multiple Functions of Protein Inhibitor of Activated STAT1 in Regulating Endothelial Cell Proliferation and Inflammation. [PDF]
Arterioscler Thromb Vasc Biol, 2016 Abe J.
europepmc +1 more source
Tissue adaptation to metabolic stress: insights from SUMOylation. [PDF]
Front Endocrinol (Lausanne)Xie H +8 more
europepmc +1 more source
Synthetic inhibition of the SUMO pathway by targeting the SAE1 component via TAK-981 compound impairs growth and chemosensitizes embryonal and alveolar rhabdomyosarcoma cell lines. [PDF]
Mol Cell BiochemCodenotti S +5 more
europepmc +1 more source
SENP6 restricts the IFN-I-induced signaling pathway and antiviral activity by deSUMOylating USP8. [PDF]
Cell Mol ImmunolGuo J, Zheng H, Xiong S.
europepmc +1 more source